Product logins

Find logins to all Clarivate products below.

home   •  Research Reports  •  Disease Landscape and Forecast Insights

Opioid Addiction | DecisionBase | US/EU5 | 2014

Login to access report north_east
Contact sales account_box

How Will Physicians and Payers Value Advances in Drug Delivery?

Opioid addiction is a debilitating, chronic relapsing disorder affecting nearly 5 million people in the seven major markets under study (United States, France, Germany, Italy, Spain, United Kingdom, and Japan). The buprenorphine/naloxone sublingual film (Reckitt Benckiser Pharmaceuticals’ Suboxone) was the patient- and market-share leader in 2012 owing to its familiarity to physicians and lack of administration restrictions compared with other opioid replacement therapies. Additional buprenorphine/naloxone formulations and the buprenorphine implant (Titan Pharmaceuticals/Braeburn Pharmaceuticals’ Probuphine) will offer delivery advantages over existing products; however, with limited drug development in opioid addiction, our surveyed psychiatrists and payers agree that significant opportunity remains for therapies that can offer improvement in reducing the use of opioids, as well as the risk of misuse, abuse, and diversion in this difficult-to-treat population.

Contact sales account_box
Login to access report north_east

Related Market Assessment Reports

Report
Psoriasis – Geographic Focus: China – Psoriasis | China In-Depth | China | 2025
Psoriasis is a chronic dermatologic condition with rising prevalence in China, particularly in urban areas where heightened awareness and improved access to care have led to higher diagnosis rates…
north_east
Report
Chronic Kidney Disease – Geographic Focus: China – Chronic Kidney Disease – China In-Depth (China)
Chronic kidney disease (CKD) is an irreversible condition requiring lifelong management. In China, CKD is notably widespread, particularly among older adults and those with chronic risk factors…
north_east
Report
Type 2 Diabetes – Geographic Focus: China – Type 2 Diabetes – China In-Depth (China)
In China, type 2 diabetes (T2D) continues to be a leading public health concern, with the highest global prevalence. Biguanides continue to dominate the market, but the use of SGLT-2 inhibitors and…
north_east
Report
Eosinophilic Esophagitis – Current Treatment – Treatment Algorithms: Claims Data Analysis – Eosinophilic Esophagitis (US)
Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory condition of the esophagus, marked by an accumulation of eosinophils. This can lead to difficulty swallowing and potentially…
north_east
Report
Metabolic Dysfunction-Associated Steatohepatitis – Unmet Need – Unmet Need – Metabolic Dysfunction-Associated Steatohepatitis (US/EU)
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), has the potential to be a large and lucrative therapy market owing to the disease…
north_east

Follow us

Contact us

Sales enquiries north_east
Customer service north_east
Support north_east